{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:27:44Z","timestamp":1787239664661,"version":"build-2736575974"},"reference-count":207,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ccl.2010.04.005","type":"journal-article","created":{"date-parts":[[2010,7,11]],"date-time":"2010-07-11T21:18:36Z","timestamp":1278883116000},"page":"477-496","source":"Crossref","is-referenced-by-count":35,"title":["The Genetics of Vascular Complications in Diabetes Mellitus"],"prefix":"10.1016","volume":"28","author":[{"given":"Dan","family":"Farbstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib1","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/dc08-9017","article-title":"Economic costs of diabetes in the U.S. in 2007","volume":"31","author":"American Diabetes Association","year":"2008","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pharmthera.2006.05.002","article-title":"Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy","volume":"112","author":"Levy","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"Pt 5","key":"10.1016\/j.ccl.2010.04.005_bib3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1469-1809.2008.00446.x","article-title":"Genetic epidemiology of subclinical cardiovascular disease in the diabetes heart study","volume":"72","author":"Bowden","year":"2008","journal-title":"Ann Hum Genet"},{"issue":"20","key":"10.1016\/j.ccl.2010.04.005_bib4","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/jama.2008.649","article-title":"Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes","volume":"300","author":"Doria","year":"2008","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ccl.2010.04.005_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ymgme.2006.01.008","article-title":"The angiotensin-I converting enzyme I\/D polymorphism is not associated with type 2 diabetes in individuals undergoing coronary angiography. (The Ludwigshafen Risk and Cardiovascular Health Study)","volume":"88","author":"Grammer","year":"2006","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1464-5491.2005.01777.x","article-title":"Association analysis of genes in the renin-angiotensin system with subclinical cardiovascular disease in families with Type 2 diabetes mellitus: the Diabetes Heart Study","volume":"23","author":"Burdon","year":"2006","journal-title":"Diabet Med"},{"issue":"Pt 4","key":"10.1016\/j.ccl.2010.04.005_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1469-1809.2006.00340.x","article-title":"Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects","volume":"71","author":"Gable","year":"2007","journal-title":"Ann Hum Genet"},{"issue":"10","key":"10.1016\/j.ccl.2010.04.005_bib8","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/eurheartj\/ehp090","article-title":"Association between the adiponectin promoter rs266729 gene variant and oxidative stress in patients with diabetes mellitus","volume":"30","author":"Prior","year":"2009","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ccl.2010.04.005_bib9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1464-5491.2004.01224.x","article-title":"The adiponectin gene SNP+45 is associated with coronary artery disease in Type 2 (non-insulin-dependent) diabetes mellitus","volume":"21","author":"Lacquemant","year":"2004","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.ccl.2010.04.005_bib10","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2337\/db05-1520","article-title":"Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes","volume":"55","author":"Qi","year":"2006","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jdiacomp.2009.01.007","article-title":"Association of genetic variants in the adiponectin encoding gene (ADIPOQ) with type 2 diabetes in Japanese Brazilians","volume":"24","author":"Vendramini","year":"2010","journal-title":"J Diabetes Complications"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.metabol.2007.09.012","article-title":"Adiponectin gene polymorphism 45T>G is associated with carotid artery plaques in patients with type 2 diabetes mellitus","volume":"57","author":"Kim","year":"2008","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.ccl.2010.04.005_bib13","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2337\/diacare.27.8.2015","article-title":"The +276 G\/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients","volume":"27","author":"Bacci","year":"2004","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.ccl.2010.04.005_bib14","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.2337\/db06-0613","article-title":"Common haplotypes at the adiponectin receptor 1 (ADIPOR1) locus are associated with increased risk of coronary artery disease in type 2 diabetes","volume":"55","author":"Soccio","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ccl.2010.04.005_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2369-10-9","article-title":"Genetic polymorphisms of angiotensin-2 type 1 receptor and angiotensinogen and risk of renal dysfunction and coronary heart disease in type 2 diabetes mellitus","volume":"10","author":"Lin","year":"2009","journal-title":"BMC Nephrol"},{"issue":"18","key":"10.1016\/j.ccl.2010.04.005_bib16","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1073\/pnas.0602178103","article-title":"A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease","volume":"103","author":"Tuncman","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.ccl.2010.04.005_bib17","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1007\/s00125-006-0317-1","article-title":"The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes","volume":"49","author":"Kretowski","year":"2006","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.atherosclerosis.2009.06.036","article-title":"Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with type 2 diabetes mellitus","volume":"208","author":"Winkler","year":"2009","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ahj.2005.05.004","article-title":"Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS)","volume":"151","author":"Burdon","year":"2006","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.ccl.2010.04.005_bib20","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jmg.2004.029850","article-title":"Association of genes of lipid metabolism with measures of subclinical cardiovascular disease in the Diabetes Heart Study","volume":"42","author":"Burdon","year":"2005","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.atherosclerosis.2008.07.018","article-title":"Association of polymorphisms in cyclooxygenase (COX)-2 with coronary and carotid calcium in the Diabetes Heart Study","volume":"203","author":"Rudock","year":"2009","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.atherosclerosis.2005.03.006","article-title":"RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients","volume":"183","author":"Boger","year":"2005","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1900\/RDS.2006.3.21","article-title":"ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population","volume":"3","author":"Chen","year":"2006","journal-title":"Rev Diabet Stud"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3132\/dvdr.2008.021","article-title":"Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study","volume":"5","author":"Burdon","year":"2008","journal-title":"Diab Vasc Dis Res"},{"issue":"8","key":"10.1016\/j.ccl.2010.04.005_bib25","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.mad.2005.03.007","article-title":"1267 HSP70-2 polymorphism as a risk factor for carotid plaque rupture and cerebral ischaemia in old type 2 diabetes-atherosclerotic patients","volume":"126","author":"Giacconi","year":"2005","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.ccl.2010.04.005_bib26","article-title":"Association of a functional polymorphism (C59038T) in GTP cyclohydrolase 1 gene and Type 2 diabetic macrovascular disease in the Chinese population","author":"Liao","year":"2009","journal-title":"J Diabetes Complications"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2005.05.017","article-title":"A common variant in the glutathione S transferase gene is associated with elevated markers of inflammation and lipid peroxidation in subjects with diabetes mellitus","volume":"184","author":"Hayek","year":"2006","journal-title":"Atherosclerosis"},{"issue":"22","key":"10.1016\/j.ccl.2010.04.005_bib28","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1161\/CIRCULATIONAHA.104.509224","article-title":"Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study","volume":"111","author":"Doney","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1191\/1358863x05vm617oa","article-title":"Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus","volume":"10","author":"Danielsson","year":"2005","journal-title":"Vasc Med"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ymgme.2007.12.006","article-title":"+647 A\/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular\u00a0complications","volume":"94","author":"Giacconi","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"9","key":"10.1016\/j.ccl.2010.04.005_bib31","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.humimm.2006.05.006","article-title":"NFkappaB and its inhibitor IkappaB in relation to type 2 diabetes and its microvascular and atherosclerotic complications","volume":"67","author":"Romzova","year":"2006","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ymgme.2009.01.012","article-title":"The C609T variant of NQO1 is associated with carotid artery plaques in patients with type 2 diabetes","volume":"97","author":"Han","year":"2009","journal-title":"Mol Genet Metab"},{"issue":"1\u20132","key":"10.1016\/j.ccl.2010.04.005_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cca.2008.06.015","article-title":"Type 2 diabetes significantly modulates the cardiovascular risk conferred by the PAI-1 -675 4G\/5G polymorphism in angiographied coronary patients","volume":"396","author":"Saely","year":"2008","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2005.08.034","article-title":"The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT)","volume":"187","author":"Tai","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ccl.2010.04.005_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1478-1336-3-4","article-title":"Association of common variation in the PPARA gene with incident myocardial infarction in individuals with type 2 diabetes: a Go-DARTS study","volume":"3","author":"Doney","year":"2005","journal-title":"Nucl Recept"},{"issue":"6","key":"10.1016\/j.ccl.2010.04.005_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.numecd.2005.07.002","article-title":"P-selectin gene genotypes or haplotypes and cardiovascular complications in type 2 diabetes mellitus","volume":"16","author":"Zalewski","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2337\/diabetes.55.03.06.db05-0058","article-title":"Association of protein tyrosine phosphatase-N1 polymorphisms with coronary calcified plaque in the Diabetes Heart Study","volume":"55","author":"Burdon","year":"2006","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib38","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ndt\/gfl641","article-title":"Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients","volume":"22","author":"Buraczynska","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ccl.2010.04.005_bib39","first-page":"336","article-title":"Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy","volume":"12","author":"Suganthalakshmi","year":"2006","journal-title":"Mol Vis"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib40","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1006\/geno.1996.0225","article-title":"The human serum paraoxonase\/arylesterase gene (PON1) is one member of a multigene family","volume":"33","author":"Primo-Parmo","year":"1996","journal-title":"Genomics"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib41","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1432-1033.1993.tb17620.x","article-title":"Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase","volume":"211","author":"Blatter","year":"1993","journal-title":"Eur J Biochem"},{"issue":"4","key":"10.1016\/j.ccl.2010.04.005_bib42","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/01.ATV.21.4.542","article-title":"Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids","volume":"21","author":"Reddy","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"48","key":"10.1016\/j.ccl.2010.04.005_bib43","doi-asserted-by":"crossref","first-page":"44444","DOI":"10.1074\/jbc.M105660200","article-title":"Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein","volume":"276","author":"Ng","year":"2001","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.ccl.2010.04.005_bib44","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1194\/jlr.M400511-JLR200","article-title":"Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities","volume":"46","author":"Draganov","year":"2005","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.ccl.2010.04.005_bib45","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MOL.0b013e32832ca1ee","article-title":"The roles of PON1 and PON2 in cardiovascular disease and innate immunity","volume":"20","author":"Shih","year":"2009","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"10.1016\/j.ccl.2010.04.005_bib46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.ATV.21.4.473","article-title":"Paraoxonase and atherosclerosis","volume":"21","author":"Durrington","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"17","key":"10.1016\/j.ccl.2010.04.005_bib47","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.febslet.2005.05.060","article-title":"Quorum quenching enzyme activity is widely conserved in the sera of mammalian species","volume":"579","author":"Yang","year":"2005","journal-title":"FEBS Lett"},{"issue":"1\u20132","key":"10.1016\/j.ccl.2010.04.005_bib48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein","volume":"286","author":"Mackness","year":"1991","journal-title":"FEBS Lett"},{"issue":"6","key":"10.1016\/j.ccl.2010.04.005_bib49","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1172\/JCI118359","article-title":"Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein","volume":"96","author":"Watson","year":"1995","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.ccl.2010.04.005_bib50","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase","volume":"101","author":"Aviram","year":"1998","journal-title":"J Clin Invest"},{"issue":"6690","key":"10.1016\/j.ccl.2010.04.005_bib51","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"Shih","year":"1998","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.ccl.2010.04.005_bib52","doi-asserted-by":"crossref","first-page":"17527","DOI":"10.1074\/jbc.M910376199","article-title":"Combined serum paraoxonase knockout\/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis","volume":"275","author":"Shih","year":"2000","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.ccl.2010.04.005_bib53","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.CIR.0000023623.87083.4F","article-title":"Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice","volume":"106","author":"Tward","year":"2002","journal-title":"Circulation"},{"issue":"Pt 2","key":"10.1016\/j.ccl.2010.04.005_bib54","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1042\/bj20021670","article-title":"Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor","volume":"372","author":"Deakin","year":"2003","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib55","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.ATV.20.2.516","article-title":"Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations","volume":"20","author":"Leviev","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.ccl.2010.04.005_bib56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s001090100240","article-title":"Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease","volume":"79","author":"Leviev","year":"2001","journal-title":"J Mol Med"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib57","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.ATV.0000051702.38086.C1","article-title":"Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population","volume":"23","author":"Wang","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib58","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.thromres.2008.03.004","article-title":"Paraoxonase 1 gene promoter polymorphisms are associated with the extent of stenosis in coronary arteries","volume":"123","author":"Najafi","year":"2009","journal-title":"Thromb Res"},{"issue":"24","key":"10.1016\/j.ccl.2010.04.005_bib59","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa021445","article-title":"Prediction of the risk of myocardial infarction from polymorphisms in candidate genes","volume":"347","author":"Yamada","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib60","first-page":"598","article-title":"Molecular basis for the polymorphic forms of human serum paraoxonase\/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes","volume":"52","author":"Adkins","year":"1993","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.ccl.2010.04.005_bib61","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","article-title":"Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk","volume":"299","author":"Bhattacharyya","year":"2008","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ccl.2010.04.005_bib62","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1194\/jlr.M600297-JLR200","article-title":"The 192R\/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux","volume":"47","author":"Gaidukov","year":"2006","journal-title":"J Lipid Res"},{"issue":"9410","key":"10.1016\/j.ccl.2010.04.005_bib63","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(04)15642-0","article-title":"Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies","volume":"363","author":"Wheeler","year":"2004","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ccl.2010.04.005_bib64","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/01.ATV.0000081635.96290.D3","article-title":"Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease","volume":"23","author":"Jarvik","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.ccl.2010.04.005_bib65","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/hq0901.094247","article-title":"Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?","volume":"21","author":"Mackness","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib66","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0021-9150(98)00095-1","article-title":"Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus","volume":"139","author":"Mackness","year":"1998","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.ccl.2010.04.005_bib67","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1053\/meta.2000.17724","article-title":"Serum arylesterase\/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes","volume":"49","author":"Inoue","year":"2000","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.ccl.2010.04.005_bib68","doi-asserted-by":"crossref","first-page":"717","DOI":"10.33549\/physiolres.931285","article-title":"Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus","volume":"57","author":"Flekac","year":"2008","journal-title":"Physiol Res"},{"issue":"11","key":"10.1016\/j.ccl.2010.04.005_bib69","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.2337\/db06-0723","article-title":"Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes","volume":"55","author":"Mastorikou","year":"2006","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ccl.2010.04.005_bib70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2362.2002.00977.x","article-title":"Serum paraoxonase activity in patients with type\u00a01 diabetes compared to healthy controls","volume":"32","author":"Mackness","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib71","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1464-5491.2007.02328.x","article-title":"Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study)","volume":"25","author":"van den Berg","year":"2008","journal-title":"Diabet Med"},{"issue":"11","key":"10.1016\/j.ccl.2010.04.005_bib72","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.freeradbiomed.2008.02.012","article-title":"Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties","volume":"44","author":"Rozenberg","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib73","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00592-008-0066-3","article-title":"Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes","volume":"46","author":"Ikeda","year":"2009","journal-title":"Acta Diabetol"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib74","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1042\/CS19990239","article-title":"Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy","volume":"98","author":"Mackness","year":"2000","journal-title":"Clin Sci (Lond)"},{"issue":"1\u20132","key":"10.1016\/j.ccl.2010.04.005_bib75","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cccn.2005.03.046","article-title":"Investigation of the relationship between atherosclerosis and paraoxonase or homocysteine thiolactonase activity in patients with type 2 diabetes mellitus using a commercially available assay","volume":"359","author":"Kosaka","year":"2005","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.ccl.2010.04.005_bib76","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0026-0495(98)90246-3","article-title":"Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus","volume":"47","author":"Ikeda","year":"1998","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.ccl.2010.04.005_bib77","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.2337\/diabetes.49.8.1390","article-title":"Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients","volume":"49","author":"James","year":"2000","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib78","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.metabol.2003.10.009","article-title":"Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes","volume":"53","author":"Tsuzura","year":"2004","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib79","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/CS20050089","article-title":"Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in type II diabetes","volume":"109","author":"Sampson","year":"2005","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib80","doi-asserted-by":"crossref","first-page":"287","DOI":"10.33549\/physiolres.930530","article-title":"Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidant-antioxidant system in Turkish patients with type 2 diabetes mellitus","volume":"54","author":"Agachan","year":"2005","journal-title":"Physiol Res"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib81","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2337\/diabetes.48.3.623","article-title":"Paraoxonase 192 Gln\/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes","volume":"48","author":"Pfohl","year":"1999","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.ccl.2010.04.005_bib82","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1464-5491.2004.01252.x","article-title":"Paraoxonase 1 Gln\/Arg polymorphism is associated with the risk of microangiopathy in type 2 diabetes mellitus","volume":"21","author":"Murata","year":"2004","journal-title":"Diabet Med"},{"issue":"7","key":"10.1016\/j.ccl.2010.04.005_bib83","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1210\/jc.82.7.2257","article-title":"Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus","volume":"82","author":"Odawara","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"8979","key":"10.1016\/j.ccl.2010.04.005_bib84","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(95)92709-3","article-title":"Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes","volume":"346","author":"Ruiz","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/euhj.1999.1660","article-title":"Risk of myocardial infarction associated with Gln\/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators","volume":"21","author":"Aubo","year":"2000","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib86","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/01.GIM.0000151152.78092.CA","article-title":"PON1 polymorphism, diabetes mellitus, obesity, and risk of myocardial infarction: modifying effect of diabetes mellitus and obesity on the association between PON1 polymorphism and myocardial infarction","volume":"7","author":"Li","year":"2005","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.ccl.2010.04.005_bib87","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0955-2863(90)90070-2","article-title":"Methionine metabolism in mammals","volume":"1","author":"Finkelstein","year":"1990","journal-title":"J Nutr Biochem"},{"issue":"Suppl 9","key":"10.1016\/j.ccl.2010.04.005_bib88","first-page":"155","article-title":"The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease","volume":"59","author":"Jakubowski","year":"2008","journal-title":"J Physiol Pharmacol"},{"issue":"8","key":"10.1016\/j.ccl.2010.04.005_bib89","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.febslet.2009.03.038","article-title":"Homocysteine and lipids: S-adenosyl methionine as a key intermediate","volume":"583","author":"Obeid","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ccl.2010.04.005_bib90","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.med.49.1.31","article-title":"Homocysteine and cardiovascular disease","volume":"49","author":"Refsum","year":"1998","journal-title":"Annu Rev Med"},{"issue":"5","key":"10.1016\/j.ccl.2010.04.005_bib91","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2796.1999.00512.x","article-title":"Total homocysteine and cardiovascular disease","volume":"246","author":"Nygard","year":"1999","journal-title":"J Intern Med"},{"issue":"1\u20132","key":"10.1016\/j.ccl.2010.04.005_bib92","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11010-006-9204-9","article-title":"Comparative study on in vitro effects of homocysteine thiolactone and homocysteine on HUVEC cells: evidence for a stronger proapoptotic and proinflammative homocysteine thiolactone","volume":"291","author":"Kerkeni","year":"2006","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"10.1016\/j.ccl.2010.04.005_bib93","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIRCRESAHA.108.171082","article-title":"Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation","volume":"102","author":"Chang","year":"2008","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.ccl.2010.04.005_bib94","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1182\/blood-2007-06-096701","article-title":"Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene","volume":"110","author":"Jamaluddin","year":"2007","journal-title":"Blood"},{"issue":"40","key":"10.1016\/j.ccl.2010.04.005_bib95","doi-asserted-by":"crossref","first-page":"25380","DOI":"10.1074\/jbc.272.40.25380","article-title":"Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine","volume":"272","author":"Wang","year":"1997","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib96","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1172\/JCI118383","article-title":"Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells","volume":"97","author":"Tsai","year":"1996","journal-title":"J Clin Invest"},{"issue":"14","key":"10.1016\/j.ccl.2010.04.005_bib97","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.1073\/pnas.91.14.6369","article-title":"Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis","volume":"91","author":"Tsai","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib98","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib99","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejvs.2009.05.007","article-title":"Homocysteine and peripheral arterial disease: systematic review and meta-analysis","volume":"38","author":"Khandanpour","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"11","key":"10.1016\/j.ccl.2010.04.005_bib100","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4065\/83.11.1203","article-title":"Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis","volume":"83","author":"Humphrey","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"16","key":"10.1016\/j.ccl.2010.04.005_bib101","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ccl.2010.04.005_bib102","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.amjcard.2009.05.011","article-title":"Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease","volume":"104","author":"Mager","year":"2009","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib103","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2796.2009.02077.x","article-title":"Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function","volume":"266","author":"Van Guelpen","year":"2009","journal-title":"J Intern Med"},{"issue":"17","key":"10.1016\/j.ccl.2010.04.005_bib104","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial","volume":"299","author":"Albert","year":"2008","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.ccl.2010.04.005_bib105","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.296.22.2720","article-title":"Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"296","author":"Bazzano","year":"2006","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ccl.2010.04.005_bib106","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.ccl.2010.04.005_bib107","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ccl.2010.04.005_bib108","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"issue":"9576","key":"10.1016\/j.ccl.2010.04.005_bib109","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(07)60854-X","article-title":"Efficacy of folic acid supplementation in stroke prevention: a meta-analysis","volume":"369","author":"Wang","year":"2007","journal-title":"Lancet"},{"issue":"9576","key":"10.1016\/j.ccl.2010.04.005_bib110","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(07)60830-7","article-title":"Lowering homocysteine for stroke prevention","volume":"369","author":"Carlsson","year":"2007","journal-title":"Lancet"},{"issue":"9168","key":"10.1016\/j.ccl.2010.04.005_bib111","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(98)05381-1","article-title":"Plasma homocysteine and all-cause mortality in diabetes","volume":"353","author":"Kark","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib112","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.18.1.133","article-title":"Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study","volume":"18","author":"Hoogeveen","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib113","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2337\/dc07-0632","article-title":"Homocysteine and diabetic retinopathy","volume":"31","author":"Brazionis","year":"2008","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib114","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1365-2796.2003.01113.x","article-title":"Hyperhomocysteinaemia is associated with coronary events in type 2 diabetes","volume":"253","author":"Becker","year":"2003","journal-title":"J Intern Med"},{"issue":"12","key":"10.1016\/j.ccl.2010.04.005_bib115","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/diacare.23.12.1816","article-title":"Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance","volume":"23","author":"Buysschaert","year":"2000","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib116","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.numecd.2004.03.001","article-title":"Reduced serum homocysteine levels in type 2 diabetes","volume":"15","author":"Mazza","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib117","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.numecd.2006.03.007","article-title":"Circulating homocysteine levels in patients with type 2 diabetes mellitus","volume":"18","author":"Ndrepepa","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib118","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2337\/diacare.24.3.533","article-title":"Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes","volume":"24","author":"Emoto","year":"2001","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib119","first-page":"35","article-title":"Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease","volume":"58","author":"Kluijtmans","year":"1996","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.ccl.2010.04.005_bib120","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1161\/01.CIR.94.12.3074","article-title":"Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease","volume":"94","author":"Deloughery","year":"1996","journal-title":"Circulation"},{"issue":"7524","key":"10.1016\/j.ccl.2010.04.005_bib121","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/bmj.38611.658947.55","article-title":"Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?","volume":"331","author":"Lewis","year":"2005","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib122","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jvs.2008.10.004","article-title":"Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: a case-control study and meta-analysis","volume":"49","author":"Khandanpour","year":"2009","journal-title":"J Vasc Surg"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib123","first-page":"145","article-title":"The relationship between MTHFR gene polymorphisms, plasma homocysteine levels and diabetic retinopathy in type 2 diabetes mellitus","volume":"116","author":"Sun","year":"2003","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib124","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jdiacomp.2006.12.002","article-title":"MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients","volume":"22","author":"Maeda","year":"2008","journal-title":"J Diabetes Complications"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib125","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2337\/diacare.26.2.547-a","article-title":"MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation","volume":"26","author":"Maeda","year":"2003","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.ccl.2010.04.005_bib126","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/ndt\/gfg211","article-title":"Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy","volume":"18","author":"Moczulski","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib127","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12020-009-9218-7","article-title":"Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy","volume":"36","author":"Ukinc","year":"2009","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib128","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.diabres.2003.10.022","article-title":"Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients","volume":"64","author":"Sun","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.ccl.2010.04.005_bib129","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1053\/meta.2000.6254","article-title":"Lack of association between carotid intima-media thickness and methylenetetrahydrofolate reductase gene polymorphism or serum homocysteine in non-insulin-dependent diabetes mellitus","volume":"49","author":"Mazza","year":"2000","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.ccl.2010.04.005_bib130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1464-5491.2006.01841.x","article-title":"The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes","volume":"23","author":"Hermans","year":"2006","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.ccl.2010.04.005_bib131","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s12253-009-9163-z","article-title":"Methylentetrahydrofolate Reductase and Nitric Oxide Synthase Polymorphism in Patients with Atherosclerosis and Diabetes","volume":"15","author":"Szabo","year":"2009","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib132","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1008962220476","article-title":"Serum homocysteine, MTHFR gene polymorphism, and carotid intimal-medial thickness in NIDDM subjects","volume":"8","author":"Mazza","year":"1999","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"6","key":"10.1016\/j.ccl.2010.04.005_bib133","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1042\/CS20010323","article-title":"Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects","volume":"102","author":"Kaye","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ccl.2010.04.005_bib134","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2840-4-17","article-title":"Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes","volume":"4","author":"Pollex","year":"2005","journal-title":"Cardiovasc Diabetol"},{"issue":"1\u20132","key":"10.1016\/j.ccl.2010.04.005_bib135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mce.2004.09.003","article-title":"Methylenetetrahydrofolate reductase polymorphism associated with susceptibility to coronary heart disease in Chinese type 2 diabetic patients","volume":"229","author":"Sun","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ccl.2010.04.005_bib136","article-title":"Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study","author":"Russo","year":"2009","journal-title":"Acta Diabetol"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib137","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cardiores.2007.03.023","article-title":"Life history of eNOS: partners and pathways","volume":"75","author":"Dudzinski","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib138","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8","article-title":"Nitric oxide in the pathogenesis of vascular disease","volume":"190","author":"Li","year":"2000","journal-title":"J Pathol"},{"issue":"8","key":"10.1016\/j.ccl.2010.04.005_bib139","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s12272-009-1801-1","article-title":"Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases","volume":"32","author":"Napoli","year":"2009","journal-title":"Arch Pharm Res"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/152308601300185142","article-title":"Direct and indirect antioxidant effects of nitric oxide: radically unsettled issues","volume":"3","author":"Kagan","year":"2001","journal-title":"Antioxid Redox Signal"},{"issue":"23","key":"10.1016\/j.ccl.2010.04.005_bib141","doi-asserted-by":"crossref","first-page":"17478","DOI":"10.1016\/S0021-9258(19)85359-0","article-title":"Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene","volume":"268","author":"Marsden","year":"1993","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib142","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0008-6363(99)00115-7","article-title":"Enzymatic function of nitric oxide synthases","volume":"43","author":"Andrew","year":"1999","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.ccl.2010.04.005_bib143","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/jcp.2006.040550","article-title":"Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis","volume":"60","author":"Napoli","year":"2007","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1016\/j.ccl.2010.04.005_bib144","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1073\/pnas.97.6.2832","article-title":"Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298","volume":"97","author":"Tesauro","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/hmg\/11.3.229","article-title":"Modifier effect of ENOS in autosomal dominant polycystic kidney disease","volume":"11","author":"Persu","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"28","key":"10.1016\/j.ccl.2010.04.005_bib146","doi-asserted-by":"crossref","first-page":"26674","DOI":"10.1074\/jbc.M103647200","article-title":"Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)\u2013>Asp variant of human endothelial nitric-oxide synthase","volume":"276","author":"Fairchild","year":"2001","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.ccl.2010.04.005_bib147","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/00008571-200412000-00006","article-title":"Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells","volume":"14","author":"McDonald","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib148","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1089-8603(02)00131-3","article-title":"Functional characterization of Glu298Asp mutant human endothelial nitric oxide synthase purified from a yeast expression system","volume":"8","author":"Golser","year":"2003","journal-title":"Nitric Oxide"},{"issue":"6","key":"10.1016\/j.ccl.2010.04.005_bib149","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/01.STR.0000126482.86708.37","article-title":"Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298\u2013>Asp and T-786\u2013>C polymorphisms","volume":"35","author":"Paradossi","year":"2004","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.ccl.2010.04.005_bib150","doi-asserted-by":"crossref","first-page":"H1908","DOI":"10.1152\/ajpheart.2001.281.5.H1908","article-title":"eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia","volume":"281","author":"Naber","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"24","key":"10.1016\/j.ccl.2010.04.005_bib151","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1161\/01.CIR.99.24.3096","article-title":"G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine","volume":"99","author":"Philip","year":"1999","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccl.2010.04.005_bib152","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.amjhyper.2004.02.013","article-title":"Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans","volume":"17","author":"Li","year":"2004","journal-title":"Am J Hypertens"},{"issue":"6","key":"10.1016\/j.ccl.2010.04.005_bib153","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0735-1097(02)03011-5","article-title":"The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients","volume":"41","author":"Rossi","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib154","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2362.2003.01108.x","article-title":"Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and forearm vascular reactivity in two Austrian populations","volume":"33","author":"Schmoelzer","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ccl.2010.04.005_bib155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2261-5-27","article-title":"A common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions","volume":"5","author":"Lamblin","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib156","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.atherosclerosis.2007.09.037","article-title":"Glu298Asp polymorphism of the eNOS gene is associated with coronary collateral development","volume":"198","author":"Gulec","year":"2008","journal-title":"Atherosclerosis"},{"issue":"18","key":"10.1016\/j.ccl.2010.04.005_bib157","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1093\/hmg\/9.18.2629","article-title":"Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T\u2013>C mutation associated with coronary spastic angina","volume":"9","author":"Miyamoto","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.ccl.2010.04.005_bib158","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.RES.0000145359.47708.2f","article-title":"Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease","volume":"95","author":"Cattaruzza","year":"2004","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.ccl.2010.04.005_bib159","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1021\/pr800998k","article-title":"T-786C polymorphism of the NOS-3 gene and the endothelial cell response to fluid shear stress-a proteome analysis","volume":"8","author":"Asif","year":"2009","journal-title":"J Proteome Res"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-5793(00)01356-9","article-title":"Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity","volume":"471","author":"Wang","year":"2000","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib161","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/bbrc.1998.8267","article-title":"Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans","volume":"245","author":"Tsukada","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.ccl.2010.04.005_bib162","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/hy1101.092967","article-title":"Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease","volume":"38","author":"Jeerooburkhan","year":"2001","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.ccl.2010.04.005_bib163","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/clinchem\/46.10.1626","article-title":"Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease","volume":"46","author":"Yoon","year":"2000","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib164","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2143\/AC.63.2.2029533","article-title":"Lack of evidence for contribution of intron4a\/b polymorphism of endothelial nitric oxide synthase (NOS3) gene to plasma nitric oxide levels","volume":"63","author":"Salimi","year":"2008","journal-title":"Acta Cardiol"},{"issue":"10","key":"10.1016\/j.ccl.2010.04.005_bib165","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/aje\/kwj302","article-title":"Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review","volume":"164","author":"Casas","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib166","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/heart.85.3.342","article-title":"Endothelial function and nitric oxide: clinical relevance","volume":"85","author":"Vallance","year":"2001","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.ccl.2010.04.005_bib167","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tem.2009.03.005","article-title":"eNOS, metabolic syndrome and cardiovascular disease","volume":"20","author":"Huang","year":"2009","journal-title":"Trends Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ccl.2010.04.005_bib168","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1464-5491.2005.01713.x","article-title":"A T-786C polymorphism in 5'-flanking region of the endothelial nitric oxide synthase gene and endothelium-dependent arterial dilation in Type 2 diabetes","volume":"22","author":"Guang-da","year":"2005","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib169","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-2007-1004527","article-title":"Endothelial NO-synthase intron 4 polymorphism is associated with disturbed in vivo nitric oxide production in individuals prone to type 2 diabetes","volume":"40","author":"Rittig","year":"2008","journal-title":"Horm Metab Res"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib170","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.niox.2006.12.007","article-title":"Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients","volume":"16","author":"Sandrim","year":"2007","journal-title":"Nitric Oxide"},{"issue":"10","key":"10.1016\/j.ccl.2010.04.005_bib171","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/GIM.0b013e3181b2046b","article-title":"Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: a HuGE review and meta-analysis","volume":"11","author":"Zintzaras","year":"2009","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.ccl.2010.04.005_bib172","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2337\/db09-0059","article-title":"A systematic meta-analysis of genetic association studies for diabetic retinopathy","volume":"58","author":"Abhary","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.ccl.2010.04.005_bib173","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2261-8-36","article-title":"The Asp298 allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with type 2 diabetes mellitus","volume":"8","author":"Odeberg","year":"2008","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"10.1016\/j.ccl.2010.04.005_bib174","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.2337\/db05-1535","article-title":"Common variants of the endothelial nitric oxide synthase gene and the risk of coronary heart disease among U.S. diabetic men","volume":"55","author":"Zhang","year":"2006","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.ccl.2010.04.005_bib175","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.2337\/diacare.21.12.2195","article-title":"A common Glu298\u2013>Asp (894G\u2013>T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes","volume":"21","author":"Cai","year":"1998","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib176","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ymgme.2009.01.013","article-title":"The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes","volume":"97","author":"Mollsten","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ccl.2010.04.005_bib177","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4615-8315-8_3","article-title":"Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation","volume":"12","author":"Bowman","year":"1982","journal-title":"Adv Hum Genet"},{"key":"10.1016\/j.ccl.2010.04.005_bib178","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1172\/JCI103925","article-title":"Studies on hemoglobin metabolism. I. The kinetic properties of the plasma hemoglobin pool in normal man","volume":"38","author":"Garby","year":"1959","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.ccl.2010.04.005_bib179","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0002-9440(10)62319-X","article-title":"Plasma protein haptoglobin modulates renal iron loading","volume":"166","author":"Fagoonee","year":"2005","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.ccl.2010.04.005_bib180","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood.V92.6.1870","article-title":"Increased susceptibility in Hp knockout mice during acute hemolysis","volume":"92","author":"Lim","year":"1998","journal-title":"Blood"},{"issue":"6817","key":"10.1016\/j.ccl.2010.04.005_bib181","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/35051594","article-title":"Identification of the haemoglobin scavenger receptor","volume":"409","author":"Kristiansen","year":"2001","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ccl.2010.04.005_bib182","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1357-2725(01)00144-3","article-title":"CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma","volume":"34","author":"Graversen","year":"2002","journal-title":"Int J Biochem Cell Biol"},{"issue":"23","key":"10.1016\/j.ccl.2010.04.005_bib183","doi-asserted-by":"crossref","first-page":"14354","DOI":"10.1016\/S0021-9258(17)42604-4","article-title":"A biologic fenton reagent","volume":"259","author":"Sadrzadeh","year":"1984","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.ccl.2010.04.005_bib184","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1182\/blood.V98.13.3693","article-title":"Structure-function analysis of the antioxidant properties of haptoglobin","volume":"98","author":"Melamed-Frank","year":"2001","journal-title":"Blood"},{"issue":"40","key":"10.1016\/j.ccl.2010.04.005_bib185","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.1021\/bi970258a","article-title":"Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin","volume":"36","author":"Miller","year":"1997","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.ccl.2010.04.005_bib186","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2008-08-174466","article-title":"Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification","volume":"113","author":"Buehler","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ccl.2010.04.005_bib187","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/clinchem\/42.10.1589","article-title":"Biological and clinical significance of haptoglobin polymorphism in humans","volume":"42","author":"Langlois","year":"1996","journal-title":"Clin Chem"},{"issue":"11","key":"10.1016\/j.ccl.2010.04.005_bib188","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0735-1097(02)02534-2","article-title":"Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: the Strong Heart Study","volume":"40","author":"Levy","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ccl.2010.04.005_bib189","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.2337\/diabetes.54.9.2802","article-title":"Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction","volume":"54","author":"Suleiman","year":"2005","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.ccl.2010.04.005_bib190","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diacare.26.9.2628","article-title":"Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes","volume":"26","author":"Roguin","year":"2003","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.ccl.2010.04.005_bib191","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2337\/db08-0095","article-title":"Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes","volume":"57","author":"Costacou","year":"2008","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib192","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/ATVBAHA.107.153965","article-title":"Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial","volume":"28","author":"Milman","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib193","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/dmrr.654","article-title":"Retinal capillary basement membrane thickness in diabetic mice genetically modified at the haptoglobin locus","volume":"23","author":"Miller-Lotan","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"10.1016\/j.ccl.2010.04.005_bib194","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/dmrr.556","article-title":"Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus","volume":"21","author":"Miller-Lotan","year":"2005","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"10.1016\/j.ccl.2010.04.005_bib195","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/01.RES.0000251741.65179.56","article-title":"Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo","volume":"99","author":"Asleh","year":"2006","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib196","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/01.ATV.0000251020.24399.a2","article-title":"Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque","volume":"27","author":"Levy","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib197","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0021-9150(00)00690-0","article-title":"Haptoglobin polymorphism as a risk factor for coronary heart disease mortality","volume":"157","author":"De Bacquer","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ccl.2010.04.005_bib198","first-page":"1","article-title":"Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)","author":"Holme","year":"2009","journal-title":"Ann Med"},{"issue":"11","key":"10.1016\/j.ccl.2010.04.005_bib199","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.RES.0000076889.23082.F1","article-title":"Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease","volume":"92","author":"Asleh","year":"2003","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.ccl.2010.04.005_bib200","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.RES.0000156653.05853.b9","article-title":"Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo","volume":"96","author":"Asleh","year":"2005","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib201","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2009.09.002","article-title":"The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic\u00a0plaque","volume":"209","author":"Kalet-Litman","year":"2010","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib202","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.107.149435","article-title":"Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability","volume":"101","author":"Levy","year":"2007","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.ccl.2010.04.005_bib203","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.freeradbiomed.2005.02.031","article-title":"Oxidative stress and 8-iso-prostaglandin F(2alpha) induce ectodomain shedding of CD163 and release of tumor necrosis factor-alpha from human monocytes","volume":"39","author":"Timmermann","year":"2005","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.ccl.2010.04.005_bib204","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2353\/ajpath.2009.080431","article-title":"Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype","volume":"174","author":"Boyle","year":"2009","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.ccl.2010.04.005_bib205","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.2337\/db08-0450","article-title":"Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype","volume":"57","author":"Asleh","year":"2008","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ccl.2010.04.005_bib206","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2217\/thy.09.23","article-title":"Pharmacogenomics and the prevention of vascular complications in diabetes mellitus","volume":"6","author":"Farbstein","year":"2009","journal-title":"Therapy"},{"issue":"2","key":"10.1016\/j.ccl.2010.04.005_bib207","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/ars.2009.2793","article-title":"Haptoglobin: basic and clinical aspects","volume":"12","author":"Levy","year":"2010","journal-title":"Antioxid Redox Signal"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865110000457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865110000457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T21:16:30Z","timestamp":1685654190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865110000457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":207,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0733865110000457"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2010.04.005","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}